ACADIA Pharmaceuticals (ACAD) stock Forecast for 2022 – 2026
Last update: October 6, 2022 (07:24)
Sector: HealthcareThe share price of ACADIA Pharmaceuticals Inc. (ACAD) now
What analysts predict: $18.88
52-week high/low: $28.06 / $12.24
50/200 Day Moving Average: $16.4 / $19.96
This figure corresponds to the average price over the previous 50/200 days. For ACADIA Pharmaceuticals stocks, the 50-day moving average is the support level today.
For ACADIA Pharmaceuticals stocks, the 200-day moving average is the resistance level today.
Are you interested in ACADIA Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ACADIA Pharmaceuticals stock price in 2022, 2023, 2024, 2025, 2026. How much will one ACADIA Pharmaceuticals share be worth in 2022 - 2026?
When should I take profit in ACADIA Pharmaceuticals stock? When should I record a loss on ACADIA Pharmaceuticals stock? What are analysts' forecasts for ACADIA Pharmaceuticals stock? What is the future of ACADIA Pharmaceuticals stock?
We forecast ACADIA Pharmaceuticals stock performance using neural networks based on historical data on ACADIA Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
ACADIA Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ACADIA Pharmaceuticals shares. This happens once a day.
Fresh insight into ACADIA Pharmaceuticals stock
View all analyticsAcadia: Powerful Unfolding Catalysts
Summary Aside from being launched for Parkinson’s, Nuplazid is potentially gaining two additional label expansions. Trofinetide is also poised to gain FDA approval to treat the rare condition, Rett syndrome … Read more
FDA AdComm Rejects Nuplazid This Time But Acadia’s Race Isn’t Run Yet
Summary Acadia won approval for its only commercialized drug Nuplazid in 2017 and has tried and failed to expand its label since. This month an FDA AdComm voted against an … Read more
Historical and forecast chart of ACADIA Pharmaceuticals stock
The chart below shows the historical price of ACADIA Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ACADIA Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
ACADIA Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct 08 | 18.37 | 18.22 | 18.77 | 3.03 |
| Oct 09 | 18.12 | 17.93 | 18.67 | 4.17 |
| Oct 10 | 17.83 | 17.55 | 18.36 | 4.63 |
| Oct 11 | 17.99 | 17.50 | 18.52 | 5.84 |
| Oct 12 | 17.67 | 17.16 | 18.06 | 5.23 |
| Oct 13 | 18.27 | 17.94 | 18.66 | 4.03 |
| Oct 14 | 18.02 | 17.85 | 18.42 | 3.19 |
| Oct 15 | 17.72 | 17.45 | 17.89 | 2.52 |
| Oct 16 | 17.16 | 16.85 | 17.37 | 3.10 |
| Oct 17 | 17.09 | 16.74 | 17.57 | 4.98 |
| Oct 18 | 17.05 | 16.86 | 17.36 | 2.99 |
| Oct 19 | 16.91 | 16.72 | 17.43 | 4.25 |
| Oct 20 | 16.72 | 16.21 | 17.03 | 5.08 |
| Oct 21 | 17.35 | 16.88 | 17.50 | 3.70 |
| Oct 22 | 17.88 | 17.42 | 18.09 | 3.86 |
| Oct 23 | 18.16 | 17.72 | 18.56 | 4.75 |
| Oct 24 | 18.19 | 17.89 | 18.50 | 3.38 |
| Oct 25 | 18.76 | 18.19 | 19.16 | 5.32 |
| Oct 26 | 19.09 | 18.76 | 19.53 | 4.07 |
| Oct 27 | 19.46 | 19.21 | 19.99 | 4.05 |
| Oct 28 | 19.50 | 19.33 | 19.96 | 3.23 |
| Oct 29 | 19.19 | 18.94 | 19.58 | 3.41 |
| Oct 30 | 19.26 | 19.02 | 19.61 | 3.08 |
| Oct 31 | 18.97 | 18.46 | 19.44 | 5.30 |
| Nov 01 | 18.89 | 18.60 | 19.24 | 3.45 |
| Nov 02 | 19.32 | 18.97 | 19.78 | 4.24 |
| Nov 03 | 18.69 | 18.29 | 19.09 | 4.37 |
| Nov 04 | 18.50 | 18.01 | 19.03 | 5.67 |
| Nov 05 | 18.85 | 18.46 | 19.35 | 4.82 |
| Nov 06 | 18.42 | 18.09 | 18.64 | 3.06 |
ACADIA Pharmaceuticals Daily Price Targets
ACADIA Pharmaceuticals Stock Forecast 10-08-2022.
Pessimistic target level: 18.22
Optimistic target level: 18.77
ACADIA Pharmaceuticals Stock Forecast 10-09-2022.
Pessimistic target level: 17.93
Optimistic target level: 18.67
ACADIA Pharmaceuticals Stock Forecast 10-10-2022.
Pessimistic target level: 17.55
Optimistic target level: 18.36
ACADIA Pharmaceuticals Stock Forecast 10-11-2022.
Pessimistic target level: 17.50
Optimistic target level: 18.52
ACADIA Pharmaceuticals Stock Forecast 10-12-2022.
Pessimistic target level: 17.16
Optimistic target level: 18.06
ACADIA Pharmaceuticals Stock Forecast 10-13-2022.
Pessimistic target level: 17.94
Optimistic target level: 18.66
ACAD (ACAD) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Nov. | 18.92 | 17.31 | 19.38 | 10.66 |
| Dec. | 19.26 | 18.29 | 20.16 | 9.29 |
ACADIA Pharmaceuticals forecast for this year
ACADIA Pharmaceuticals Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $18.9212. Pessimistic: $17.31. Optimistic: $19.38
ACADIA Pharmaceuticals Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $19.2618. Pessimistic: $18.29. Optimistic: $20.16
ACADIA Pharmaceuticals (ACAD) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 20.16 | 19.00 | 21.23 | 10.49 |
| Feb | 18.61 | 17.52 | 20.18 | 13.17 |
| Mar | 18.41 | 16.96 | 18.90 | 10.29 |
| Apr | 19.76 | 18.91 | 21.07 | 10.24 |
| May | 20.14 | 19.10 | 21.76 | 12.22 |
| Jun | 20.55 | 18.58 | 22.15 | 16.14 |
| Jul | 20.53 | 19.57 | 21.93 | 10.78 |
| Aug | 21.27 | 19.51 | 23.26 | 16.13 |
| Sep | 22.36 | 20.67 | 23.20 | 10.88 |
| Oct | 21.05 | 20.47 | 22.21 | 7.85 |
| Nov | 22.08 | 20.07 | 22.88 | 12.28 |
| Dec | 21.45 | 20.06 | 22.81 | 12.07 |
ACADIA Pharmaceuticals (ACAD) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 21.55 | 20.41 | 22.17 | 7.93 |
| Feb | 22.87 | 21.22 | 23.91 | 11.25 |
| Mar | 23.34 | 21.57 | 24.15 | 10.67 |
| Apr | 22.13 | 20.78 | 22.77 | 8.75 |
| May | 21.04 | 19.76 | 22.91 | 13.78 |
| Jun | 21.45 | 19.49 | 22.81 | 14.55 |
| Jul | 19.88 | 18.11 | 20.90 | 13.35 |
| Aug | 20.02 | 18.58 | 20.81 | 10.73 |
| Sep | 20.09 | 18.43 | 21.59 | 14.63 |
| Oct | 19.59 | 18.48 | 20.76 | 10.98 |
| Nov | 19.84 | 19.23 | 20.49 | 6.16 |
| Dec | 22.08 | 20.02 | 23.65 | 15.35 |
ACADIA Pharmaceuticals (ACAD) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 21.13 | 19.96 | 22.35 | 10.67 |
| Feb | 20.27 | 18.81 | 22.14 | 15.05 |
| Mar | 19.25 | 18.60 | 20.22 | 8.00 |
| Apr | 17.70 | 16.34 | 18.63 | 12.31 |
| May | 16.45 | 16.01 | 16.96 | 5.59 |
| Jun | 16.05 | 14.72 | 17.40 | 15.39 |
| Jul | 17.82 | 16.33 | 18.74 | 12.89 |
| Aug | 19.51 | 18.34 | 20.73 | 11.52 |
| Sep | 18.60 | 17.55 | 20.27 | 13.43 |
| Oct | 19.25 | 17.47 | 20.03 | 12.80 |
| Nov | 19.43 | 18.17 | 20.71 | 12.27 |
| Dec | 19.24 | 17.91 | 20.45 | 12.42 |
ACADIA Pharmaceuticals (ACAD) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 21.00 | 19.71 | 21.86 | 9.80 |
| Feb | 21.55 | 20.11 | 22.93 | 12.30 |
| Mar | 19.98 | 18.90 | 20.70 | 8.69 |
| Apr | 19.98 | 18.56 | 21.53 | 13.80 |
| May | 18.97 | 17.56 | 19.81 | 11.38 |
| Jun | 20.61 | 19.15 | 21.40 | 10.52 |
| Jul | 20.68 | 18.90 | 22.00 | 14.10 |
| Aug | 21.25 | 20.16 | 22.53 | 10.53 |
| Sep | 23.37 | 22.36 | 24.46 | 8.60 |
| Oct | 24.32 | 23.10 | 25.08 | 7.91 |
| Nov | 26.54 | 24.57 | 28.23 | 12.97 |
| Dec | 28.36 | 27.61 | 31.01 | 10.97 |
ACADIA Pharmaceuticals information and performance
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, specializes in the development and commercialization of small molecule drugs designed to meet unmet medical needs in diseases of the central nervous system.
ACADIA Pharmaceuticals Address
3611 VALLEY CENTRE DRIVE, SUITE 300, SAN DIEGO, CA, US
Market Capitalization: 2 647 752 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -204 074 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: -0.42
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -1.334
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.168
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 4.371
Enterprise Value (EV) /Revenue
EV To EBITDA: -10.97
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 161843000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A